Biostar Pharmaceuticals, Inc. Accounts and Financing Receivable, after Allowance for Credit Loss, Current
Biostar Pharmaceuticals, Inc. had Accounts and Financing Receivable, after Allowance for Credit Loss, Current of $0 as of 2014-12-31, per its 10-K filed 2015-04-15.
Discontinued › Balance Sheet › Assets › Assets, Current › Receivables, Net, Current › Accounts and Financing Receivable, after Allowance for Credit Loss, Current
us-gaap:AccountsNotesAndLoansReceivableNetCurrent · last filed 2015-04-15
- 2014-12-31: Accounts and Financing Receivable, after Allowance for Credit Loss, Current $0.00.
- 2014-09-30: Accounts and Financing Receivable, after Allowance for Credit Loss, Current $0.00.
- 2014-06-30: Accounts and Financing Receivable, after Allowance for Credit Loss, Current $0.00.
- 2014-03-31: Accounts and Financing Receivable, after Allowance for Credit Loss, Current $0.00.
| Period end | Accounts and Financing Receivable, after Allowance for Credit Loss, Current |
|---|---|
| 2014-12-31 | $0.00 10-K · filed 2015-04-15 |
| 2014-09-30 | $0.00 10-Q · filed 2014-11-14 |
| 2014-06-30 | $0.00 10-Q · filed 2014-08-14 |
| 2014-03-31 | $0.00 10-Q · filed 2014-05-15 |
| 2013-12-31 | $1.39M 10-K · filed 2015-04-15 |
| 2012-12-31 | $0.00 10-K · filed 2014-03-31 |